Rovia Clinical Research Headquarters & Office Locations

Rovia Clinical Research is headquartered in Jacksonville, Florida, United States. Founded in 2007, the company has 2 recorded locations and employs approximately 125 people worldwide.

Where is Rovia Clinical Research's main office?

Rovia Clinical Research's main headquarters office is located at Jacksonville, Florida 32216, United States. This is the company's primary corporate address.

Rovia Clinical Research contact information

The main switchboard for Rovia Clinical Research headquarters can be reached at +1 904 854 1354. Official website: roviaclinical.com.

What does Rovia Clinical Research do?

Innovative medicines, cures, and products stem from innovative research initiatives. That’s where Rovia comes in. Study to study, phase to phase, patient to patient… Rovia stands at the cutting edge of clinical research. Founded in 2007 on the principles of exceptional patient care and scientific collaboration, the company is comprised of highly experienced professionals from diverse backgrounds and disciplines, including physicians, scientists, nurses, bio-pharma and therapeutic specialists certified in clinical research. This unique combination has proven to be vital to the successful design, implementation and completion of our complex clinical studies. So too has been our ability to work collaboratively with our sponsors, CROs and investigators to ensure that our studies provide unerringly precise results, supported by careful data collection and comprehensive analysis. Our efficient start-up, enrollment, and retention processes also facilitate consistent, open communication with our full research team. Located in communities throughout the southeastern U.S., our clinical research sites include those fully owned by Rovia as well as a number operated in partnership with independent medical providers. In the latter instances, Rovia specialists manage and provide complete research support on site. This novel hybrid site model has helped accelerate and advance trial site selection and activation as well as access to diverse, underserved communities. Improved patient care, research predictability, efficiency and successful outcomes are further byproducts.